Molecular mechanisms of fluoroquinolone resistance.

Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations. J Infect Dis (2012) 1.83

New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations. PLoS One (2012) 1.49

Prospective study of antibiotic prophylaxis for prostate biopsy involving >1100 men. ScientificWorldJournal (2012) 1.22

Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. BMC Microbiol (2009) 0.97

Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis. Antimicrob Agents Chemother (2009) 0.96

A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II. Antimicrob Agents Chemother (2004) 0.93

A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae. Ecotoxicology (2006) 0.84

Fluoroquinolone-resistant mutants of Burkholderia cepacia. Antimicrob Agents Chemother (2007) 0.84

The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium. PLoS One (2011) 0.83

Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa. J Clin Microbiol (2009) 0.82

Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole. PLoS One (2012) 0.82

Besifloxacin ophthalmic suspension: emerging evidence of its therapeutic value in bacterial conjunctivitis. Ophthalmol Eye Dis (2011) 0.75

Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol (2003) 1.26

CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob Agents Chemother (2004) 1.24

Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol (2004) 1.22

Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol (2007) 1.18

Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis (2004) 1.18

Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol (2005) 1.15

Methicillin-resistant Staphylococcus aureus in Taiwan. Emerg Infect Dis (2005) 1.14

Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis (2007) 1.12

Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan. J Clin Microbiol (2006) 1.11

Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis (2005) 1.09

Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One (2013) 1.04

Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect (2003) 1.03

Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS (2003) 1.03

Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis (2005) 1.01

Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Diagn Microbiol Infect Dis (2008) 0.96

Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob Agents Chemother (2002) 0.95

Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMC Infect Dis (2006) 0.94

Easy strategy to increase salt resistance of antimicrobial peptides. Antimicrob Agents Chemother (2011) 0.93

Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol (2005) 0.91

Increased potency of a novel D-beta-naphthylalanine-substituted antimicrobial peptide against fluconazole-resistant fungal pathogens. FEMS Yeast Res (2009) 0.86

Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan. J Infect Chemother (2013) 0.86

In vitro activity of voriconazole against Candida species isolated in Taiwan. Int J Antimicrob Agents (2004) 0.85

Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006. Mycoses (2009) 0.84

Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006. Microb Drug Resist (2009) 0.84

Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan. Med Mycol (2006) 0.84

Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan. Med Mycol (2013) 0.83

Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans. Fungal Genet Biol (2009) 0.83

Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients. J Negat Results Biomed (2008) 0.83

The DNA-binding domain of CaNdt80p is required to activate CDR1 involved in drug resistance in Candida albicans. J Med Microbiol (2006) 0.82

The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae. Microb Drug Resist (2003) 0.82

Serum repressing efflux pump CDR1 in Candida albicans. BMC Mol Biol (2006) 0.82

Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole. PLoS One (2012) 0.82

Molecular mechanisms of fluoroquinolone resistance in Klebsiella. Curr Drug Targets Infect Disord (2004) 0.81

Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan. J Med Microbiol (2007) 0.80

Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study. J Microbiol Immunol Infect (2012) 0.79

Oropharyngeal colonization of HIV-infected outpatients in Taiwan by yeast pathogens. J Clin Microbiol (2010) 0.78

The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan. BMC Infect Dis (2005) 0.78

Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells. Mycol Res (2008) 0.78

Loss of heterozygosity of FCY2 leading to the development of flucytosine resistance in Candida tropicalis. Antimicrob Agents Chemother (2011) 0.77

Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan. Mycopathologia (2014) 0.76

Species distribution and drug susceptibilities of Candida isolates in TSARY 2010. Diagn Microbiol Infect Dis (2013) 0.76

Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. J Microbiol Immunol Infect (2009) 0.75

Characterization of Candida species from different populations in Taiwan. Mycopathologia (2011) 0.75

Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis. Diagn Microbiol Infect Dis (2011) 0.75

Molecular epidemiology of emerging reduced susceptibility to fluoroquinolones in Escherichia coli. J Med Microbiol (2004) 0.75